Xeris Biopharma Holdings (XERS) Payables (2020 - 2026)
Xeris Biopharma Holdings (XERS) reported Payables of $9.34 million for Q2 2026, down 1.3% from $9.46 million a year earlier and down 18.6% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Xeris Biopharma Holdings posted Payables of $3.08 million, up 34.3% from FY2024.
- Payables has a five-year compound annual growth rate of -0.3% (FY2020 to FY2025).
- By year, Payables came in at $2.29 million in FY2024 (-80.2%), $11.57 million in FY2023 (+151.1%), $4.61 million in FY2022 (-48.4%) and $8.92 million in FY2021 (+186.3%).
- Five-year quarterly Payables spans a low of $2.29 million in Q4 2024 and a high of $12.08 million in Q3 2023.
- Year over year, Payables gained in three of the last eight quarters, with growth averaging 4.4%.
- The high point for year-over-year Payables in five years was Q3 2023 (growth of 208.4%); the low point was Q4 2024 (a decline of 80.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.47 million (Q1 2026), $3.08 million (Q4 2025) and $6.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Xeris Biopharma Holdings | 1.71 Bn | 1.27 Bn | 79.59 Mn | 9.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.34 Mn |
| Mar 31, 2026 | 11.47 Mn |
| Dec 31, 2025 | 3.08 Mn |
| Sep 30, 2025 | 6.53 Mn |
| Jun 30, 2025 | 9.46 Mn |
| Mar 31, 2025 | 6.35 Mn |
| Dec 31, 2024 | 2.29 Mn |
| Sep 30, 2024 | 7.45 Mn |
| Jun 30, 2024 | 5.80 Mn |
| Mar 31, 2024 | 7.09 Mn |
| Dec 31, 2023 | 11.57 Mn |
| Sep 30, 2023 | 12.08 Mn |
| Jun 30, 2023 | 11.62 Mn |
| Mar 31, 2023 | 11.98 Mn |
| Dec 31, 2022 | 4.61 Mn |
| Sep 30, 2022 | 3.92 Mn |
| Jun 30, 2022 | 6.63 Mn |
| Mar 31, 2022 | 11.09 Mn |
| Dec 31, 2021 | 8.92 Mn |
| Sep 30, 2021 | 4.29 Mn |
API Access
Xeris Biopharma Holdings Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();